α-Adrenergic Blockers for the Treatment of Lower-Urinary-Tract Symptoms and Dysfunction in Women

Annals of Pharmacotherapy

Volumn 48, Issue 6, 2014, Pages 711-722

  Boyd, Katie ^a   Hilas, Olga ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b ST JOHN'S UNIVERSITY   (United States)

Author keywords

alfuzosin; doxazosin; prazosin; silodosin; tamsulosin; terazosin; urinary dysfunction; urinary frequency; urinary incontinence and women; urinary symptoms; urinary urgency; adrenergic blockers

Indexed keywords

ALFUZOSIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; DOXAZOSIN; PRAZOSIN; TAMSULOSIN; TERAZOSIN;

ABDOMINAL PAIN; ANKLE EDEMA; ASTHENIA; BLURRED VISION; CLINICAL STUDY; COHORT ANALYSIS; CONSTIPATION; DISEASE ASSOCIATION; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; DYSPEPSIA; FATIGUE; HEADACHE; HEART PALPITATION; HUMAN; HYPOTENSION; LANGUAGE; LEG EDEMA; LOWER URINARY TRACT SYMPTOM; MEDICAL LITERATURE; MUSCLE WEAKNESS; NAUSEA; ORTHOSTATIC HYPOTENSION; OUTCOME ASSESSMENT; PHARYNX DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; REVIEW; RHINITIS; STRESS INCONTINENCE; STUDY DESIGN; TREATMENT DURATION; URINARY DYSFUNCTION; URTICARIA; XEROSTOMIA; CHEMICALLY INDUCED; FEMALE; LOWER URINARY TRACT SYMPTOMS; URINARY BLADDER NECK OBSTRUCTION;

ADRENERGIC ALPHA-ANTAGONISTS; DIZZINESS; FEMALE; HUMANS; HYPOTENSION; LOWER URINARY TRACT SYMPTOMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; URINARY BLADDER NECK OBSTRUCTION;

EID: 84899745527     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1177/1060028014524174     Document Type: Review

References (27)

1. Moller LA,Lose G,Jorgensen T.The prevalence and bothersomeness of lower urinary tract symptoms in women 40-60 years of age.Acta Obstet Gynecol Scand. 2000;79:298-305.
2. Yu HJ,Chen J,Lai MK,et al.High prevalence of voiding symptoms in Taiwanese women.Br J Urol. 1998;82:520-23.
3. Groutz A,Blaivas JG.Non-neurogenic female voiding dysfunction.Curr Opin Urol. 2002;12:311-316.
4. Lee KS,Han DH,Lee YS,et al.Efficacy and safety of tamsulosin for the treatment of non-neurogenic voiding dysfunction in females: a 8-week prospective study.J Korean Med Sci. 2010;25:117-122.
5. Ruby CM,Hanlon JT,Boudreau RM,et al.The effect of medication use on urinary incontinence in community-dwelling elderly women.J Am Geriatr Soc. 2010;58:1715-1720.
6. Robinson D,Cardozo L.New drug treatments for urinary incontinence.Maturitas. 2010;65:340-347.
7. Conner EL,Lind L.Urinary incontinence in nursing homes: epidemiology and management guidelines.Prim Care Update Ob Gyns. 2001;8:248-252.
8. Low BY,Liong ML,Yuen KH,et al.Terazosin therapy for patients with female lower urinary tract symptoms: a randomized, double-blind, placebo controlled trial.J Urol. 2008;179:1461-1469.
9. Lepor H,Theune C.Randomized double-blind study comparing the efficacy of terazosin versus placebo in women with prostatism-like symptoms.J Urol. 1995;154:116-118.
10. Pummangura N,Kochakarn W.Efficacy of tamsulosin in the treatment of lower urinary tract symptoms (LUTS) in women.Asian J Surg. 2007;30:131-137.
11. Robinson D,Cardozo L,Terpstra G,et al.A randomized double-blind placebo-controlled multicentre study to explore the efficacy and safety of tamsulosin and tolterodine in women with overactive bladder syndrome.Br J Urol. 2007;4:840-845.
12. Kim SO,Hwang EU,Oh KJ,et al.Efficacy and safety of combined therapy with tamsulosin and tolterodine in female patients with a maximal flow rate less than 12 ml/s.Int Urogynecol J. 2011;22:1287-1291.
13. Hajebrahimi S,Asrbadr YA,Azaripour A,et al.Effect of tamsulosin versus prazosin on clinical and urodynamic parameters in women with voiding difficulty: a randomized clinical trial.Int J Gen Med. 2011;4:35-39.
14. Koh JS,Kim SJ,Kim HS,Kim JC.Comparison of alpha-blocker, extracorporeal magnetic stimulation alone or in combination in the management of female bladder outlet obstruction.Int Urogynecol J. 2011;22:849-854.
15. Costantini E,Lazzeri M,Bini V,et al.Open-label, longitudinal study of tamsulosin for functional bladder outlet obstruction.Urol Int. 2009;83:311-315.
16. Athanasopoulos A,Gyftopoulos K,Giannitsas K,Perimenis P.Effect of asfuzosin on female primary bladder neck obstruction.Int Urogynecol J Pelvic Floor Dysfunct. 2009;20:217-222.
17. Chang SJ,Chiang IN,Yu HJ.The effectiveness of tamsulosin in treating women with voiding difficulty.Int J Urol. 2008;15:981-985.
18. Kessler TM,Studer UE,Burkhard FC.The effect of terazosin on functional bladder outlet obstruction in women: a pilot study.J Urol. 2006;176:1487-1492.
19. Pischedda A,Farina FP,Madonia M,Cimino S,Morgia G.Use of alpha1-blockers in female functional bladder neck obstruction.Urol Int. 2005;74:256-261.
20. Serels S,Stein M.Prospective study comparing hyoscyamine, doxazosin, and combination therapy for the treatment of urgency and frequency in women.Neurourol Urodyn. 1998;17:31-36.
21. Kumar A,Mandhani A,Gogoi S,Srivastava A.Management of functional bladder neck obstruction in women: use of a-blockers and pediatric resectoscope for bladder neck incision.J Urol. 1999;162:2061-2065.
22. Hansen BJ,Meyhoff HH,Nordling J,et al.Placebo effects in the pharmacological treatment of uncomplicated benign prostatic hyperplasia: The ALFECH Study Group.Scand J Urol Nephrol. 1996;30:373-377.
23. Lepor H,Machi G.Comparison of AUA symptom index in unselected males and females between fifty-five and seventy-nine years of age.Urology. 1993;42:36-40.
24. Hsiao SM,Lin HH,Kuo HC.International Prostate Symptom Score for assessing lower urinary tract dysfunction in women.Int Urogynecol J. 2013;24:263-267.
25. Brookes ST,Donova JL,Wright M,et al.A scored form of the Bristol Female Lower Urinary Tract Symptoms questionnaire: data from a randomized controlled trial of surgery for women with stress incontinence.Am J Obstet Gynecol. 2004;191:73-82.
26. Ghoniem G,Stanford E,Kenton K,et al.Evaluation and outcome measures in the treatment of female urinary stress incontinence: International Urogynecological Association (IUGA) guidelines for research and clinical practice.Int Urogynecol J. 2008;37:5-33.
27. Abrams P,Andersson L,Birder L,et al.Fourth international consultation on Incontinence. Recommendations of the International Science Committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence.Neurourol Urodyn. 2010;29:213-240.